| First Author | Watson SA | Year | 2006 |
| Journal | Nat Rev Cancer | Volume | 6 |
| Issue | 12 | Pages | 936-46 |
| PubMed ID | 17128210 | Mgi Jnum | J:120251 |
| Mgi Id | MGI:3706180 | Doi | 10.1038/nrc2014 |
| Citation | Watson SA, et al. (2006) Gastrin - active participant or bystander in gastric carcinogenesis?. Nat Rev Cancer 6(12):936-46 |
| abstractText | Gastrin is a pro-proliferative, anti-apoptotic hormone with a central role in acid secretion in the gastric mucosa and a long-standing association with malignant progression in transgenic mouse models. However, its exact role in human gastric malignancy requires further validation. Gastrin expression is tightly regulated by two closely associated hormones, somatostatin and gastrin-releasing peptide, and aspects of their interaction may be deregulated during progression to gastric adenocarcinoma. Furthermore, agonists and antagonists of the receptors for all three hormones have shown modest clinical efficacy against gastric adenocarcinoma, which might provide useful information on the future combined use of these agents. |
